APA (7th ed.) Citation

C, K., A, G., KS, S., E, D., S, B., AM, G., . . . MJ, F. (2025). The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma. Human genetics, 144(11-12), 1199. https://doi.org/10.1007/s00439-025-02786-2

Chicago Style (17th ed.) Citation

C, Kotch, et al. "The Spectrum of Pathogenic NF1 Variants in Participants Enrolling on Clinical Trials of MEK Inhibitors for Plexiform Neurofibroma." Human Genetics 144, no. 11-12 (2025): 1199. https://doi.org/10.1007/s00439-025-02786-2.

MLA (9th ed.) Citation

C, Kotch, et al. "The Spectrum of Pathogenic NF1 Variants in Participants Enrolling on Clinical Trials of MEK Inhibitors for Plexiform Neurofibroma." Human Genetics, vol. 144, no. 11-12, 2025, p. 1199, https://doi.org/10.1007/s00439-025-02786-2.